THE USE OF HUMAN URINARY KALLIDINOGENASE FOR THE MANUFACTURE OF A MEDICINE FOR THE TREATMENT OF ACUTE CORONARY SYNDROMES

摘要

The present invention relates to a novel pharmaceutical use of human urinary kallidinogenase in the manufacture of a medicament for the treatment and/or prevention of acute coronary syndromes. The invention also relates to the pharmaceutical compositions comprising human urinary kallidinogenase as an active ingredient. The human urinary kallidinogenase and the pharmaceutical composition containing the same are effective for the treatment of acute coronary syndromes. The human urinary kallidinogenase composition is generally used in various pharmaceutical formulation forms, preferably in form of dry powder or aqueous solution for injection.